Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.

Recruiting

Phase 2

Tropocells PRFEvaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.

Sponsor:

Estar Medical dba Medical Technologies, LTD

Code:

NCT06810726

Conditions

Diabetic Foot Ulcer

Type 1 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM)

Neuroischemic Foot Ulcer

Chronic Wound of the Lower Limb (Leg Ulcer or Foot Ulcer)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Platelet Rich Plasma

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-13. This information was provided to ClinicalTrials.gov by Estar Medical dba Medical Technologies, LTD on 2025-06-12.